207 related articles for article (PubMed ID: 10674634)
1. Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells.
Hewson QC; Lova PE; Malcolm AJ; Pearson AD; Redfern CP
Neurosci Lett; 2000 Jan; 279(2):113-6. PubMed ID: 10674634
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
3. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
4. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
5. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
6. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
7. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
Roy B; Taneja R; Chambon P
Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
[TBL] [Abstract][Full Text] [Related]
8. Retinoids increase human apolipoprotein A-11 expression through activation of the retinoid X receptor but not the retinoic acid receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Heyman RA; Staels B; Auwerx J
Mol Cell Biol; 1996 Jul; 16(7):3350-60. PubMed ID: 8668150
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
10. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
Sørensen S; Sølvsten H; Politi Y; Kragballe K
Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
[TBL] [Abstract][Full Text] [Related]
12. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.
Melino G; Draoui M; Bellincampi L; Bernassola F; Bernardini S; Piacentini M; Reichert U; Cohen P
Exp Cell Res; 1997 Aug; 235(1):55-61. PubMed ID: 9281352
[TBL] [Abstract][Full Text] [Related]
16. Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway.
Dawson MI; Elstner E; Kizaki M; Chen DL; Pakkala S; Kerner B; Koeffler HP
Blood; 1994 Jul; 84(2):446-52. PubMed ID: 8025272
[TBL] [Abstract][Full Text] [Related]
17. Retinoid-induced differentiation of neuroblastoma: comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid.
Irving H; Lovat PE; Hewson QC; Malcolm AJ; Pearson AD; Redfern CP
Eur J Cancer; 1998 Jan; 34(1):111-7. PubMed ID: 9624247
[TBL] [Abstract][Full Text] [Related]
18. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
Howell SR; Shirley MA; Ulm EH
Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
[TBL] [Abstract][Full Text] [Related]
19. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells.
Giannini G; Dawson MI; Zhang X; Thiele CJ
J Biol Chem; 1997 Oct; 272(42):26693-701. PubMed ID: 9334253
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
